FLXN Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 Dec 1970 @ 19:00):

Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions...

Stats
Today's Volume	0.00
Average Volume	2.17M
Market Cap	0.00
EPS	$-0.600 ( 2021-11-12 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.321 (3.52%)

Insider Trading

Date	Person	Action	Amount	type
2021-11-19	Newtyn Management, Llc	Sell	5 900 000	Common Stock, par value $0.001 per share
2021-11-18	Newtyn Management, Llc	Buy	0	Common Stock, par value $0.001 per share
2021-11-19	Stejbach Mark	Sell	12 631	Common Stock
2021-11-19	Stejbach Mark	Sell	25 000	Stock option (right to buy)
2021-11-19	Stejbach Mark	Sell	12 500	Stock option (right to buy)

INSIDER POWER
0.00
Last 99 transactions
Buy: 271 750 \| Sell: 9 779 666

Volume Correlation

Long: 0.20 (neutral)

Short: -0.90 (strong negative)

Signal:(61.022) Neutral

Flexion Therapeutics Inc Correlation

10 Most Positive Correlations
RETA	0.954
ZGNX	0.952
PLPC	0.948
FLMN	0.943
OSPN	0.943
FSLR	0.937
SFT	0.929
XLRN	0.925
ADMS	0.925
AAON	0.919

10 Most Negative Correlations
EYE	-0.947
LMPX	-0.935
GBNH	-0.917
RYTM	-0.909
PSHG	-0.909
MDRX	-0.9
CSTE	-0.9
TCPC	-0.899
ALHC	-0.899
STIM	-0.896

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Flexion Therapeutics Inc Correlation - Currency/Commodity

-0.42
( neutral )

-0.36
( neutral )

0.07
( neutral )

0.41
( neutral )

-0.61
( weak negative )

0.76
( moderate )

Flexion Therapeutics Inc Financials

Annual	2020
Revenue:	$85.55M
Gross Profit:	$66.30M (77.50 %)
EPS:	$-2.53

Q3	2021
Revenue:	$21.33M
Gross Profit:	$17.60M (82.52 %)
EPS:	$-0.600

Q2	2021
Revenue:	$28.18M
Gross Profit:	$23.20M (82.33 %)
EPS:	$-0.440

Q1	2021
Revenue:	$24.59M
Gross Profit:	$18.50M (75.25 %)
EPS:	$-0.570

Financial Reports:

No articles found.

Flexion Therapeutics Inc

Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions. It offers ZILRETTA, an intra-articular injection for the management of osteoarthritis (OA) pain of the knee in the United States. The company also develops FX201, a gene therapy product candidate designed to stimulate the production of an anti-inflammatory protein, interleukin-1 receptor antagonist for pain relief from OA of the knee; and FX301, an administered NaV1.7 inhibitor for the management of post-operative pain. Flexion Therapeutics, Inc. was founded in 2007 and is headquartered in Burlington, Massachusetts.